Confocal microscopy of cryosectioned inguinal adipose tissue from Dox-treated (E10.5) Pref-1-tdTomato mice after 3 weeks (P21-P42) of high fat feeding were examined for DAPI staining, direct fluorescence for tdTomato. Scale bars: (A) 250 µm, (B) 100µm.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Antibodies
Primary antibodies for immunostaining were: aSMA (rabbit, Abcam Lot # GR100205-1,1:100), CD24 (rat, BD Pharmingen Lot# 04877,1:100), CD31 (rat, BD Pharmingen Lot# 73117,1:100), CD34 (rat, BD Pharmingen Lot# 23141, 1:100), CD45 (rat, BD Pharmingen Lot # 2243975, 1:100), CD146 (mouse, Abcam Lot# GR94980-1, 1:100), FABP4 (goat, Santa Cruz Lot# G2110,1:500), Ki67 (rabbit, Abcam Lot# GR34956-2, 1:300), PDGFRα (rabbit,SantaCruz Lot# C2312,1:100), PPARγ (rabbit, SantaCruz Lot# L1709, 1:100), Pref-1 (goat, SantaCruz Lot# F2911, 1:100), Sox9 (rabbit, SantaCruz, Lot# I1807, 1:100), VE-cadherin (rabbit ,Abcam Lot# GR77655,1:100), ZFP423 (OAZ) (goat, SantaCruz Lot# L1306, 1:100). Secondary antibodies were goat-anti-rabbit Alexafluor488/594, chicken-anti-rat Alexafluor488/594, goat-anti-mouse Alexafluor 488/594, chicken-anti-goat Alexafluor488/594 (Invitrogen, 1:1000).
Generation of Pref-1 rtTA Mice
We generated Pref-1 reverse tet transactivator (rtTA) transgenice mice placing rtTA under the control of the Pref-1 promoter The construct linking the 6 kb Pref-1 promoter (MluI-NotI genomic fragment previously characterized (Lee et al., 2003; Moon et al., 2002 , Smas et al. 1993 to the reverse tetracycline transactivator protein (rtTA, or Tet-On) was utilized for the generation of these mice.
Plasmid Construction --The Pref-1 -6000LUC plasmid was generated by first ligating an AlwNI restriction fragment containing sequences from -2100 to +110 of the murine pref-1 gene, into the BglII cloning site of the luciferase reporter plasmid pGL2-Basic (Promega, Madison, WI). Then, all but -175 of the pref-1 5' flanking region was removed by digestion at the NotI site at -175 of the pref-1 promoter sequence and at the MluI site in the plasmid multicloning site. A 6000 bp pref-1 genomic fragment with MluI/NotI ends was ligated into this plasmid backbone. This -6000LUC plasmid was used as the starting plasmid to generate the Pref-1-tTA construct. The tTA insert including the SV40 polyA coding region was PCR amplified from the plasmid pUHD15-1 (A generous gift from Hermann Bujard, Center for Molecular Biology, University of Heidelberg, Heidelberg, Germany) using the following sense and antisense primers 5'-ACGACTAGTATGTCTAGATTAGATAAAAGTAAAGT-3' and 5'-CGTACTAGTCCGGCCAGACGACGA-3' and ligated into the pGEM-T easy vector using standard procedure (Promega, Madison, WI). The tTA insert was digested with SpeI giving SpeI sites on both the 5' and 3' ends of the insert and ligated with the linearized -6000LUC vector(at the XbaI site), placing the tTA coding sequence directly downstream of 6000 bp of the Pref-1 promoter.
To generate the Pref-1 rtTA construct, the same Pref-1 -6000LUC plasmid was utilized. The rtTA coding sequence was PCR amplified from the pTet-On Advanced Vector (Clontech, Mountain View, CA) using the following sense and antisense primers 5'-GAAACTAGTATGTCTAGACTGGACA-3' and 5'-ATAACTAGTGATTTTTTTCTCCATT-3' primers, and ligated into the pGEM-T easy vector (Promega, Madison, WI) using standard protocol. The rtTA insert was digested with SpeI giving SpeI restriction sites on both the 5' and 3' ends of the insert and ligated into the XbaI site of the -6000LUC vector, placing the rtTA coding sequence directly downstream of -6000 bp of the Pref-1 promoter.
The linearized DNA was gel purified and microinjected into the mouse pronucleus, which was then implanted into pseudo-pregnant female mice. The subsequent progeny were PCR-screened for germline transmission of the transgene. Transgenic expression was compared vie RT-PCR across six different founder lines, and all experiments were subsequently performed on animals generated from the same founder line.
Animals
C57Bl/6J (C57Bl6/J; stock no. 000664) tetO-HIST1H2BJ/GFP)47Efu/J; (TRE-H2BGFP, stock no. 005104, B6.Cg-Tg(tetO-Cre)1Jaw/J; (TRE-CRE, stock no. 006234), and B6;129S-Gt(ROSA)26Sortm34.1 (CAG-Syp/tdTomato)Hze/J; (Rosa26-flox-stop-flox-tdTomato, stock no. 012570), B6.Cg-Tg(tet)-DTA)1Gfi/J; (TRE-DTA, stock no. 008468) mice were purchased from the Jackson Laboratory. Mice were housed in a 12:12 light-dark cycle and chow and water were provided ad libitum. Doxycyline hydrochloride (0.5 mg/mL in 5% sucrose) was provided in the drinking water which was changed every 2-3 days. All animal experiments were approved by the University of California, Berkeley, Animal Care and Use Committee. We compared Pref-1-GFP and Pref-1-tdTomato mice with H2BGFP only and TRE-Cre-tdTomato littermate controls. We provided either a standard chow or a high fat diet (HFD; 45% of kcal from fat, 35% of kcal from carbohydrate and 20% of kcal from protein, Research Dyets). For HFD studies, HFD was provided for two weeks. All studies, unless indicated, were performed on standard chow-fed animals. Unless otherwise noted, all mice used were age-matched male littermates, with the exception of embryonic studies during which the sex was not determined. Dox was provided in the drinking water (1 mg/mL in 3% sucrose) and water was refreshed twice per week. BrdU was provided in the drinking water (0.8 mg/mL) and was refreshed daily.
Transient Transfection
For transfection, exponentially growing 3T3-L1 cells were seeded in 48-well plates and cotransfected with Pref-1 tTa or Pref-1 rtTA with tetracycline response element luciferase (TRE-LUC, a gift from Hermann Bujard) or tetracycline response element Green Fluorescent Protein (pTRE-Tight-BI-AcGFP, Clontech, Mountain View, CA) using Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) following manufacturer's instructions. To normalize for the efficiency of transient transfection, cells were cotransfected with Renilla luciferase expression vector (pGL4.75, Promega, Madison, WI). The Dual Luciferase Reporter Assay System (Promega, Madison, WI) was used to analyze luciferase expression following standard protocol. 3T3-L1 cells were analyzed under a fluorescent microscope 48 hours after treatment as described below. GFP fluorescence was observed under illumination using a FITC filter set. Fluorescent images of cells were obtained under 10X or 20X magnification on a Leica DM IRB microscope (Leica Microsystems, Wetzlar, Germany) using a Nikon E995 camera (Nikon Instruments, Lewisville, TX). Cells were treated with doxycycline (0 ug/mL, 2 ug/mL, 4 ug/mL and 8 ug/mL) 48 hours after transfection and imaged after 40 hours of treatment.
Adipocyte/SVF Fractionation
Adipocytes were isolated as previously described (Jaworski et al., 2009) . Briefly, SV cells were isolated from pooled white adipose depots (inguinal, perigonadal, retroperitoneal, and interscapular) which were minced into small pieces. The minced tissue was then digested in adipocyte isolation buffer (100 mM HEPES, 120mM NaCl, 50mM KCl, 5mM glucose, 1mM CaCl 2 , 1.5% BSA) containing 1 mg/ml collagenase at 37˚C with constant slow shaking for 1 hour. After passing this suspension through an 100 µm mesh to remove undigested debris, the effluent was centrifuged at 100xg for 10 minutes and the pellet washed once in 5 ml in PBS. The pellet containing the stromal-vascular fraction was washed and either subjected to FACS or cultured.
Immunostaining and Immunocytochemistry
Frozen sections were stored at -20˚C until staining, and processed within two weeks of freezing. Briefly, slides were allowed to warm to room temperature for 5 minutes, fixed in 4% formalin phosphate buffered saline for 30 minutes at room temperature, blocked in 5% BSA in PBST (PBS with 0.025% Triton X-100), and incubated with the appropriate antibody diluted in 2.5% BSA in PBST overnight at 4˚C. Slides were washed 3 times in PBST, and incubated with secondary antibody for 2 hours at room temperature. Slides were then washed twice in PBST, and stained with DAPI for three minutes, washed once, and mounted in 15% glycerol in PBS with glass coverslips. Antibodies used for immunostaining are listed above.
FACS Analysis and Sorting
FACS were carried out on a FACSAria flow cytometer. Briefly, fresh adipose tissue was fractionated, and the stromal vascular fraction was washed three times, and resuspended in 5% FBS/PBS at a concentration of 10 6 cells/mL, and strained through a 40 µm mesh. For quantification, cells were initially selected by size on the basis of forward scatter (FSC) or side scatter (SSC). Dead cells were excluded based on propidium idodide uptake. The stromal vascular fraction from control mice were used to determine background fluorescence levels. Sorting experiments were carried out on a Cytopeia INFLUX Sorter. A similar protocol was followed as above for culture and maintenance, however, after sorting, cells were collected in 5% FBS in Ham's F12 media, and plated in 6 cm dishes.
Cell RT-qPCR
Freshly isolated WAT was fractionated by centrifugation and the stromal vascular fraction was resuspended in 2% FBS/PBS at a concentration of 10 6 cells/mL. Cells were fixed in 4% formalin in buffered PBS for 15 min at room temperature, and washed three times in DPBS (without Mg +2 or Ca +2 ). Cells were applied to the single cell device and centrifuged at 3,000 rpm for 10 min twice. The device was then dried at 37˚C for 30 minutes prior to application of SuperScript III with Platinum Taq DNA Polymerase and Taqman probes (Life Technologies). Pref-1 was detected using Taqman probe (Mm00494477_m1) with VIC. A Biorad CFX96 Realtime PCR was used for thermocycling prior to imaging.
Subcutaneous Transplant
Primary SVF cells were isolated from fractionated freshly dissected adipose tissue, washed three times, and plated in 10%FBS in DMEM with 5% penicillin/streptomycin. Cells were cultured to 80% confluency and mixed with matrigel prior to subcutaneous injection. Cultured 3T3-L1 and HepG2 cell lines were used as controls. Cells were injected on the right and left dorsal side of each SCID mouse. Implants were allowed to grow for 2-3 weeks until a small bump was visible, upon which the implants were dissected and analyzed.
High Fat Diet and BrdU Labeling
Pref-1-GFP mice were given Dox at E0, which was removed upon weaning at 3 weeks of age, and mice were maintained without Dox on chow or high fat diet for 3 weeks. A bolus of BrdU was injected, followed by one week of BrdU (0.2mg/mL) administered in the drinking water, one week prior to sacrifice. 
